Compare GXO Logistics Inc (GXO) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GXO Logistics Inc vs TransMedics Group Inc — how do they compare? GXO Logistics Inc trades at $46.56 (market cap $5.32B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: GXO Logistics Inc is the larger of the two by market cap, and TransMedics Group Inc is more actively traded (949,331 versus 1,255,816). Which is the better fit depends on your goals — on Pluang, investors hold GXO Logistics Inc for 28 Days and TransMedics Group Inc for 24 Days on average.
| GXO | TMDX | |
|---|---|---|
Market Cap | $5.32B | $2.74B |
Volume | 1,255,816 | 949,331 |
Sector | Industrials | Health |
52-Week High | $65.59 | $150.42 |
52-Week Low | $44.17 | $61.99 |
Typical Hold Time | 28 Days | 24 Days |
Enterprise Value | $10.67B | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GXO trades at $46.56, up 1.24% today, with a neutral technical signal and bearish moving average trend. The company reported Q2 2026 EPS of $0.59, beating estimates, and maintains strong analyst support with an 88.89% buy rating. Recent news highlights strategic partnerships with Columbia Sportswear and expansion in aerospace & defense, signaling growth initiatives. Revenue for 2025 was $13.18 billion, with a net income margin of 0.96%, though profitability remains modest.
The outlook is positive, driven by analyst consensus price target of $66.67 and improving industry prospects. Key opportunities include operational efficiency gains from new labor management systems and sector tailwinds. Risks involve stagnant margins and competitive pressures, requiring close monitoring of execution on growth targets to justify current valuations.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GXO Logistics Inc
GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
